Jing Du

Title: Innovations in Prostate Cancer Assessment by Jing Du

Introduction

Jing Du is an accomplished inventor based in Evanston, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in the assessment of prostate cancer. With a total of 2 patents, his work focuses on innovative methods for distinguishing between aggressive and indolent forms of prostatic adenocarcinoma.

Latest Patents

Jing Du's latest patents include groundbreaking materials and methods for assessing the progression of prostate cancer. One of his notable inventions involves methods for distinguishing and identifying patients with aggressive or indolent prostatic adenocarcinoma. This process comprises contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions. The invention also includes determining the presence of chromosomal abnormalities in the sample, along with sets of probes for use in such methods. Additionally, kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive or indolent prostatic adenocarcinoma are part of his innovative contributions.

Career Highlights

Jing Du is currently associated with Abbott Molecular Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact the way prostate cancer is diagnosed and treated, providing valuable insights into patient care.

Collaborations

Jing collaborates with talented individuals in his field, including Ying Zhang and Ekaterina Pestova, who contribute to the innovative environment at Abbott Molecular Inc.

Conclusion

Jing Du's contributions to the field of prostate cancer assessment exemplify the importance of innovation in medical diagnostics. His patents reflect a commitment to improving patient outcomes through advanced technology and research.